Immunohistochemical analysis showed that 91.7% (22 of 24) of Stage II and 83.3% (5 of 6) of Stage III breast cancers demonstrated positive expression of GPR81 (Fig. 8a, Table 1). This evidence concerns the gene HCAR1 and breast cancer.